Nexentis below Nasdaq equity rule, has 45 days
Rhea-AI Filing Summary
Nexentis Technologies Inc. (NXTS) has been notified by Nasdaq that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing under Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 of stockholders’ equity. Nexentis reported $1,782,000 of stockholders’ equity as of June 30, 2026 in its Form 10‑Q.
The notice does not immediately affect trading of Nexentis common stock on The Nasdaq Capital Market. The company has 45 days, until October 15, 2026, to submit a plan to regain compliance. If Nasdaq accepts the plan, Nexentis may receive up to a 180‑day extension through February 27, 2027 to restore compliance. If a plan is not accepted or compliance is not regained, Nasdaq staff would issue a delisting determination, which Nexentis could appeal to a Nasdaq Hearings Panel, staying any delisting while the appeal is pending.
Positive
- None.
Negative
- Noncompliance with Nasdaq equity standard: Stockholders’ equity was $1,782,000 as of June 30, 2026, below the $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1), creating a formal deficiency and potential delisting risk if compliance is not regained.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Key Figures
Nasdaq minimum stockholders’ equity requirement: $2,500,000
Nexentis stockholders’ equity: $1,782,000
Deficiency plan period: 45 days
+2 more
5 metrics
Nasdaq minimum stockholders’ equity requirement
$2,500,000
Required under Nasdaq Listing Rule 5550(b)(1) for continued listing
Nexentis stockholders’ equity
$1,782,000
As of June 30, 2026, reported in Form 10‑Q
Deficiency plan period
45 days
Time from August 31, 2026 to submit compliance plan, until October 15, 2026
Maximum extension period
180 days
Potential extension through February 27, 2027 if plan is accepted
Trading market
The Nasdaq Capital Market
Current listing venue for Nexentis common stock
Key Terms
stockholders’ equity, Nasdaq Listing Rule 5550(b)(1), continued listing, Nasdaq Hearings Panel
4 terms
stockholders’ equity financial
"the Company’s stockholders’ equity as of June 30, 2026 was $1,782,000"
Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.
Nasdaq Listing Rule 5550(b)(1) regulatory
"minimum stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1)"
continued listing regulatory
"minimum stockholders’ equity requirement for continued listing on Nasdaq"
When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.
Nasdaq Hearings Panel regulatory
"entitled to request a hearing before a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
FAQ
What Nasdaq issue did Nexentis Technologies Inc. (NXTS) disclose?
Nexentis disclosed that Nasdaq notified the company it no longer meets the minimum $2,500,000 stockholders’ equity requirement for continued listing under Nasdaq Listing Rule 5550(b)(1), based on equity of $1,782,000 reported as of June 30, 2026.
What was Nexentis (NXTS) stockholders’ equity at June 30, 2026?
As reported in its Form 10‑Q, Nexentis had stockholders’ equity of $1,782,000 as of June 30, 2026, compared with the $2,500,000 minimum required for continued listing on The Nasdaq Capital Market.
Does the Nasdaq deficiency notice immediately affect trading of NXTS stock?
No. The company states the Nasdaq deficiency letter has no immediate impact on the listing of its common stock on The Nasdaq Capital Market while it pursues a compliance plan and any available extensions or hearings.
How long does Nexentis (NXTS) have to submit a Nasdaq compliance plan?
Nexentis has 45 calendar days from the August 31, 2026 letter, or until October 15, 2026, to submit a plan to regain compliance with the Nasdaq stockholders’ equity requirement.
What extension period could Nexentis (NXTS) receive to regain Nasdaq compliance?
If Nasdaq staff accepts the company’s compliance plan, Nexentis may be granted an extension of up to 180 calendar days from the August 31, 2026 notice, through February 27, 2027, to regain compliance with the stockholders’ equity requirement.
What happens if Nexentis (NXTS) cannot regain Nasdaq compliance?
If the plan is not accepted or compliance is not regained within any extension, Nasdaq staff would issue a delisting determination. Nexentis would then be entitled to request a hearing before a Nasdaq Hearings Panel, which would stay any delisting action while the hearing process proceeds.
AI-generated analysis. How Rhea-AI works. Not financial advice.
